Nevertheless, AnxA5-based approaches could become a suitable tool to overcome poor obstetric outcomes caused by antiphospholipid syndrome, preeclampsia and SLE in humans [252] (Table 5b,c). The gene discussed is ANXA5; the disease is antiphospholipid syndrome.